Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Experimental treatment significantly slows progression of a fatal brain disease in women during clinical trial

Researchers at Tel Aviv University have presented new findings indicating that the experimental drug Davunetide may significantly slow the progression of progressive supranuclear palsy (PSP) in women, who exhibited a markedly different response to treatment than men. These results reinforce the need for sex-specific medicine in neurodegenerative diseases.

Experimental treatment significantly slows progression of a fatal brain disease in women during clinical trial

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Sunday 2 August →